I Tomida, RG Pertwee, A Azuara-Blanco - British Journal of Ophthalmology, 2004 - bjo.bmj.com Cannabis was introduced on a larger scale into Western medicine during the 19th
century, primarily by British doctors. They accumulated experience in the use of
“Indian hemp” while working in the colonies, recommending it as an ... Cited by 31 - Related articles - BL Direct - All 9 versions
FY Chien, RF Wang, TW Mittag, SM Podos - Archives of Ophthalmology, 2003 - Am Med Assoc Results In normal monkeys, a single dose of WIN 55212-2 reduced intraocular
pressure for 4, 5, or 6 hours, with a maximum reduction of 1.4 ± 0.4 (mean ±
SEM) mm Hg, 2.9 ± 0.4 mm Hg, and 3.4 ± 0.6 mm Hg following the 0.07%, ... Cited by 17 - Related articles - BL Direct - All 4 versions
BK Colasanti, CR Craig, RD Allara - Experimental eye research, 1984 - ncbi.nlm.nih.gov Cannabinol or cannabigerol was administered to cats topically in doses of 250,
500 and 1000 micrograms as a single drop or chronically via osmotic minipumps
(20 micrograms hr-1) over a period of 9 days. While cannabinol had a modest ... Cited by 11 - Related articles - All 3 versions
[CITATION] Pharmacological actions of cannabinoids
- ►iovs.org [PDF] AJ Straiker, G Maguire, K Mackie, J Lindsey - Investigative ophthalmology & visual science, 1999 - ARVO The dogs used in this study were derived from miniature poodles and were
homozygous normal or affected with the prcd mutation; the dogs were bred and
raised as part of a colony supported by an NEI/NIH grant (EY06855, ... Cited by 59 - Related articles - BL Direct - All 3 versions
- ►aspetjournals.org ZH Song, CA Slowey - Journal of Pharmacology and Experimental …, 2000 - ASPET It is known that marijuana smoking and administration of natural cannabinoids
reduce intraocular pressure. However, it has not been established whether the
intraocular pressure-lowering effects of cannabinoids are mediated by ... Cited by 48 - Related articles - BL Direct - All 3 versions
RG Pertwee - Current Neuropharmacology, 2004 - ingentaconnect.com Abstract: There is convincing evidence that mammalian tissues express at least
two types of cannabinoid receptor, CB 1 and CB 2 , and that the endogenous
cannabinoid, anandamide, and certain other eicosanoid agonists for known ... Cited by 37 - Related articles - BL Direct
A Porcella, C Maxia, GL Gessa, L Pani - European Journal of Neuroscience, 2001 - interscience.wiley.com The search for new ocular hypotensive agents represents a frontier of current
eye research because blindness due to optic neuropathy occurs insidiously in 10%
of all patients affected by glaucoma. Cannabinoids have been proposed to ... Cited by 55 - Related articles - BL Direct - All 4 versions
J Chen, I Matias, T Dinh, T Lu, S Venezia, A … - Biochemical and Biophysical Research …, 2005 - Elsevier Cannabinoid CB 1 receptors are involved in ocular physiology and may regulate
intraocular pressure (IOP). However, endocannabinoid levels in human ocular
tissues of cornea, iris, ciliary body, retina, and choroid from normal and ... Cited by 18 - Related articles - All 4 versions
T Järvinen, DW Pate, K Laine - Pharmacology and Therapeutics, 2002 - Elsevier The leading cause of irreversible blindness is glaucoma, a disease normally
characterized by the development of ocular hypertension and consequent damage to
the optic nerve at its point of retinal attachment. This results in a ... Cited by 56 - Related articles - All 4 versions
